Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

351
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
351
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

319
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
319
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

2.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in immunotherapy for lung cancer: balance or bias?

Thorax·2026
Same author

Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non-Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT).

JCO global oncology·2026
Same author

Systematic Review and Meta-Analysis of Lung Cancer Diagnostic Methods by the Brazilian Thoracic Oncology Group (GBOT).

JCO global oncology·2026
Same author

Prevalence of Genomic Alterations in <i>EGFR</i>, <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Among Early-Stage Nonsquamous Non-Small Cell Lung Cancer in Brazil.

JCO global oncology·2026
Same author

Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022.

Cancer research communications·2025
Same author

Challenges and Opportunities for Cancer Clinical Trials Development in Latin America.

JCO global oncology·2025

Related Experiment Video

Updated: Oct 10, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.0K

Malignant pleural mesothelioma: an update.

Glaucia N M Hajj1,2, Carolina H Cavarson1,2, Clóvis Antônio Lopes Pinto3

  • 1Instituto International de Pesquisa, A.C. Camargo Cancer Center, São Paulo (SP), Brasil.

Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
|December 15, 2021
PubMed
Summary

Malignant mesotheliomas are rare, asbestos-linked cancers affecting the pleura and peritoneum. This review covers their molecular basis, diagnosis, and limited treatment options, highlighting the challenges in early detection and patient survival.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.0K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.3K

Related Experiment Videos

Last Updated: Oct 10, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.0K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.0K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.3K

Area of Science:

  • Oncology
  • Pathology
  • Environmental Medicine

Background:

  • Malignant mesotheliomas are rare cancers originating in the mesothelial lining of organs, commonly the pleura and peritoneum.
  • Asbestos exposure is a primary risk factor, but the disease has a long latency period (over 30 years), complicating early diagnosis.
  • Current treatment options are limited, with a poor prognosis and survival typically ranging from 12 to 36 months.

Purpose of the Study:

  • To review the molecular physiopathology of malignant mesothelioma.
  • To discuss current diagnostic challenges and advancements.
  • To explore the latest therapeutic strategies for malignant mesothelioma.

Main Methods:

  • Literature review of molecular mechanisms.
  • Analysis of diagnostic techniques.
  • Synthesis of recent therapeutic developments.

Main Results:

  • Detailed discussion of molecular pathways implicated in mesothelioma development.
  • Overview of diagnostic modalities and their limitations.
  • Summary of emerging and established treatment approaches.

Conclusions:

  • Malignant mesothelioma presents significant diagnostic and therapeutic challenges due to its rarity and association with asbestos.
  • Understanding the molecular underpinnings is crucial for developing novel diagnostic and treatment strategies.
  • Further research is needed to improve early detection and patient outcomes for this aggressive cancer.